HealthLynked Appoints Insurance and Benefits Experts to Board Amid Expansion Push

HealthLynked Corp. (OTCQB: HLYK) has appointed Chris G. Pulos of Marsh McLennan Agency and Jason Bishara of NSI Insurance Group to its Board of Directors. The company stated these appointments bring decades of experience in employer benefits, payer strategy, insurance and risk management to support its expansion efforts. Founder and CEO Dr. Michael Dent emphasized that the new directors' expertise will be instrumental in the national scaling of the HealthLynked Network and its artificial intelligence platform, ARI. The appointments also strengthen corporate governance as the company prepares for a planned listing on the Nasdaq Capital Market.

HealthLynked is an AI-driven global healthcare network focused on improving care coordination and reducing costs through its cloud-based platform. The company's platform connects patients with healthcare providers for both virtual and in-office appointments while consolidating medical records into a single secure location. With AI-driven insights and integrated telehealth services, HealthLynked aims to empower patients and providers to coordinate care more effectively while delivering savings on prescriptions and healthcare services. The latest news and updates relating to the company are available in its newsroom at https://nnw.fm/HLYLK.

Dr. Dent noted that the board additions come at a critical time as HealthLynked expands collaborations with insurers, employer groups and healthcare organizations. The company's enterprise partnerships offer scalable solutions to healthcare networks and digital health innovators seeking to improve care management while controlling costs. The full press release announcing these board appointments can be viewed at https://nnw.fm/9abXg.

These appointments matter because they signal HealthLynked's strategic focus on strengthening relationships with insurance providers and employer groups, which are crucial for scaling healthcare technology platforms. The expertise in payer strategy and risk management directly addresses key barriers to adoption in the healthcare industry, where reimbursement models and regulatory compliance significantly influence technology implementation. By adding directors with deep insurance industry connections, HealthLynked positions itself to navigate complex healthcare payment systems more effectively, potentially accelerating adoption of its AI platform among institutional clients.

The timing of these appointments coincides with the company's planned Nasdaq listing, suggesting HealthLynked is bolstering governance and industry credibility ahead of increased public market scrutiny. For investors and healthcare stakeholders, this move indicates HealthLynked is prioritizing partnerships with established insurance entities rather than pursuing a direct-to-consumer strategy alone. The implications extend beyond corporate governance to potential business model evolution, as insurance and employer relationships could drive recurring enterprise revenue streams while expanding the platform's user base through group enrollments. This strategic board expansion reflects the growing convergence of digital health platforms with traditional healthcare payment and benefits administration systems.